Literature DB >> 1961255

The energy requirements for the basal efflux of 3H-noradrenaline from sympathetically innervated organs.

H Russ1, E Schömig, U Trendelenburg.   

Abstract

In the rat vas deferens (preloaded with 3H-noradrenaline, catechol-O-methyl transferase inhibited, calcium-free solution) ouabain, glucose deprivation or the combination of hypoxia plus presence of lactate were found to induce a carrier-mediated (desipramine-sensitive) outward transport of the 3H-amine. Glucose deprivation additionally increased the efflux of deaminated 3H-metabolites, as a consequence of an increased net leakage of vesicular 3H-noradrenaline; moreover, 3H-dihydroxymandelic acid then became the predominant neuronal metabolite. The simultaneous lack of oxygen and glucose resulted in a very pronounced release of the 3H-amine. Moreover, during spontaneous efflux more outward transport of 3H-noradrenaline was observed in the absence than in the presence of extracellular calcium. In rat atria (under the same experimental conditions) the contribution by carrier-mediated outward transport to the spontaneous efflux of tritium exceeded that in vasa deferentia. Moreover, the efflux of lactate (as an index of hypoxia of the tissue) exceeded that observed in vasa deferentia, under aerobic and anaerobic conditions. It is proposed that the greater contribution by outward transport of 3H-noradrenaline to spontaneous efflux in atria than in vasa deferentia does not reflect any basic difference between the varicosities in two different organs. It is likely that the less heterogeneous distribution of the 3H-amine in atria than in vasa deferentia is responsible for storage of the exogenous amine in atrial varicosities that are subject to some hypoxia, to an increased extracellular lactate level and to perhaps a minor degree of glucose deficiency; these factors may well be responsible for the difference with regard to outward transport of 3H-noradrenaline during spontaneous efflux. Thus, in addition to the heterogeneity of the distribution of 3H-noradrenaline, an additional heterogeneity with regard to the energy supply must be expected for incubated organs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961255     DOI: 10.1007/bf00183002

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.

Authors:  I Azevedo; D Moura; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

3.  Metabolic requirements for the uptake and storage of norepinephrine by the isolated left atrium of the guinea pig.

Authors:  A R Wakade; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1968-09       Impact factor: 4.030

4.  Cation and metabolic requirements for retention of metaraminol by rat uterine horns.

Authors:  D M Paton
Journal:  Br J Pharmacol Chemother       Date:  1968-06

5.  Different intracellular cation-content present in right and left ventricle dependent on varying extracellular Ca2+-concentrations.

Authors:  K Schrör; A Sadat-Khonsari; R Krebs
Journal:  J Mol Cell Cardiol       Date:  1979-01       Impact factor: 5.000

6.  The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat.

Authors:  E Schömig; P Fischer; C L Schönfeld; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

7.  The effect of partial inhibition of monoamine oxidase on the steady-state rate of deamination of 3H-catecholamines in two metabolizing systems.

Authors:  L Cassis; J Ludwig; M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

8.  Electrical properties of individual cells isolated from adult rat ventricular myocardium.

Authors:  T Powell; D A Terrar; V W Twist
Journal:  J Physiol       Date:  1980-05       Impact factor: 5.182

9.  Simulation of outward transport of neuronal 3H-noradrenaline with the help of a two-compartment model.

Authors:  E Schömig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

10.  Ouabain-evoked norepinephrine release from intact rat sympathetic neurons: evidence for carrier-mediated release.

Authors:  K J Sweadner
Journal:  J Neurosci       Date:  1985-09       Impact factor: 6.167

View more
  6 in total

1.  The influence of the density of adrenergic innervation on the extracellular steady-state concentration gradient for 3H-noradrenaline.

Authors:  E Schömig; I Azevedo; D Moura; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

2.  Carrier-mediated outward transport of dopamine from adrenergic varicosities of the vas deferens of reserpine-pretreated rats.

Authors:  A Langeloh; T Halbrügge; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

3.  Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens.

Authors:  J Gonçalves; G Queiroz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

4.  Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.

Authors:  J L Fitzgerald; J J Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

5.  Effects of 6-hydroxydopamine on noradrenaline metabolism linked to neuronal uptake1 and extraneuronal uptake1 in dental pulp in vitro.

Authors:  D A Parker; V Marino; J Dally; I S de la Lande
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

6.  The sensitivity of adrenergic varicosities to the 3H-noradrenaline-releasing effect of potassium.

Authors:  C L Schönfeld; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.